Trulieve Cannabis (TRLV) Current Deferred Revenue (2020 - 2026)

Trulieve Cannabis (TRLV) has reported Current Deferred Revenue for 7 consecutive years, with $10.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Current Deferred Revenue rose 14.62% year-over-year to $10.0 million; the TTM figure through Mar 2026 stood at $10.0 million (up 14.62% YoY), while the FY2025 annual figure was $9.6 million, up 19.49% from the prior year.
• Current Deferred Revenue came in at $10.0 million for Q1 2026 at Trulieve Cannabis, up from $9.6 million in the prior quarter.
• The five-year high for Current Deferred Revenue was $10.0 million in Q1 2026, with the low at $1.3 million in Q4 2023.
• Average Current Deferred Revenue over 5 years is $6.5 million, with a median of $6.5 million recorded in 2022.
• Across the five-year window, Current Deferred Revenue slumped 85.89% in 2023 and soared 501.35% in 2024, its largest moves.
• Year by year, Current Deferred Revenue stood at $9.5 million in 2022, then plunged by 85.89% to $1.3 million in 2023, then jumped by 501.35% to $8.0 million in 2024, then advanced by 19.49% to $9.6 million in 2025, then advanced by 3.76% to $10.0 million in 2026.
• According to Business Quant data, Current Deferred Revenue over the past three periods registered $10.0 million, $9.6 million, and $8.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.